person
Mathurin F.
- Country
- France
- Department
- Hepato-gastroenterology
Research Overview
assignment
39
Clinical Trials ·
- Phase 3, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Duvakitug for Induction Therapy in Moderately to Severely Active Crohn's Disease
- Efficacy and Safety of Duvakitug for Maintenance Therapy in Participants with Moderately to Severely Active Crohn’s Disease: A Phase 3, Randomized, Placebo-Controlled Study
- Comparison of Vedolizumab, Filgotinib, Ustekinumab, and Infliximab as First-Line Advanced Therapy to Maintain Remission in Patients with Ulcerative Colitis
Data & Insights
medical_services
Primary Speciality
Main therapeutic area
handshake
Return Partnerships
Recurring site collaborations
453
Sites with multiple studies
Has run more than one trial at 453 of 642 partner sites.
Specializations
Inflammatory Bowel Disease Management
The investigator specializes in treating Crohn's disease and ulcerative colitis, with particular focus on innovative therapeutic approaches for patients with moderate to severe disease activity.
- Perianal Crohn's Disease Treatment
- Post-operative Crohn's Disease Management
- Therapeutic Drug Monitoring
Novel Therapeutic Approaches
Expertise in evaluating emerging treatments including biological therapies and small molecule drugs for inflammatory bowel conditions.
- Combination Therapy Strategies
- Biologic Treatment Optimization
- Alternative Treatment Pathways
Treatment Innovation
Focus on developing personalized treatment approaches and investigating the efficacy of novel therapeutic agents in inflammatory bowel disease.
- Telemedicine Monitoring
- Patient Education Programs
- Cardiovascular Risk Assessment
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.